Valuation: Danaher Corporation

Capitalization 134B 114B 106B 99.61B 186B 12,480B 189B 1,241B 486B 5,993B 504B 493B 21,353B P/E ratio 2026 *
29.6x
P/E ratio 2027 * 25.2x
Enterprise value 145B 123B 114B 107B 200B 13,457B 204B 1,338B 524B 6,462B 543B 531B 23,025B EV / Sales 2026 *
5.65x
EV / Sales 2027 * 5.16x
Free-Float
72.69%
Yield 2026 *
0.71%
Yield 2027 * 0.77%
1 day-1.75%
1 week-0.79%
Current month+0.01%
1 month-2.87%
3 months-20.46%
6 months-6.35%
Current year-17.17%
1 week 188.73
Extreme 188.73
198.56
1 month 181.01
Extreme 181.01
198.56
Current year 181.01
Extreme 181.01
242.8
1 year 180.03
Extreme 180.03
242.8
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 2020-08-31
Director of Finance/CFO - 2026-02-27
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 74 1999-06-30
Chairman 74 1982-12-31
Director/Board Member 69 1982-12-31
Change 5d. change 1-year change 3-years change Capi.($)
-1.75%-0.79%+4.90%-24.02% 134B
-0.87%+0.95%+16.07%-13.62% 184B
-0.95%-0.32%-7.95%+74.02% 160B
+0.83%-1.64%-33.30%+22.75% 91.83B
+1.15%+4.95%-12.99%-30.47% 49.47B
-1.62%-3.92%+14.08%-5.90% 44.9B
+0.37%+4.02%+17.50%-9.19% 33.39B
+0.39%+2.13%+8.70%+3.03% 33.2B
-0.29%-0.36%+15.12%-16.64% 32.52B
+0.74%+5.18%+1.70%+6.87% 31.41B
Average -0.16%+1.19%+2.38%+0.68% 79.53B
Weighted average by Cap. -0.48%+0.66%+0.88%+7.42%

Financials

2026 *2027 *
Net sales 25.61B 21.82B 20.19B 19.01B 35.42B 2,382B 36.14B 237B 92.69B 1,144B 96.12B 94.08B 4,076B 27.09B 23.08B 21.36B 20.11B 37.45B 2,519B 38.22B 251B 98.03B 1,210B 102B 99.5B 4,310B
Net income 4.61B 3.93B 3.63B 3.42B 6.38B 429B 6.51B 42.64B 16.69B 206B 17.3B 16.94B 734B 5.51B 4.69B 4.34B 4.09B 7.61B 512B 7.77B 50.93B 19.93B 246B 20.66B 20.22B 876B
Net Debt 10.51B 8.95B 8.28B 7.8B 14.53B 977B 14.83B 97.19B 38.03B 469B 39.43B 38.6B 1,672B 5.59B 4.76B 4.41B 4.15B 7.73B 520B 7.89B 51.71B 20.23B 250B 20.98B 20.54B 890B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
26-04-10 189.61 $ -1.75% 3,189,026
26-04-09 192.99 $ -1.63% 2,903,201
26-04-08 196.19 $ +2.71% 2,610,024
26-04-07 191.01 $ -0.58% 2,932,668
26-04-06 192.12 $ +0.52% 2,595,678
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
189.61USD
Average target price
261.36USD
Spread / Average Target
+37.84%

Quarterly revenue - Rate of surprise